Results 71 to 80 of about 5,625 (178)

Safety of tiotropium [PDF]

BMJ, 2011
openaire   +2 more sources

Tiotropium in asthma: a systematic review

Journal of Asthma and Allergy, 2014
Elizabeth Befekadu,1 Claudia Onofrei,1 Gene L Colice1,2 1MedStar Washington Hospital Center, Washington, DC, USA; 2The George Washington University School of Medicine and Health Sciences, Washington, DC, USA Introduction: The objective of this paper is ...
Befekadu E, Onofrei C, Colice GL
doaj  

Effects of tiotropium on sympathetic activation during exercise in stable chronic obstructive pulmonary disease patients

International Journal of COPD, 2012
Kenji Yoshimura, Ryoji Maekura, Toru Hiraga, Seigo Kitada, Keisuke Miki, Mari Miki, Yoshitaka TateishiDepartment of Respiratory Medicine, Toneyama National Hospital, Osaka, JapanBackground: Tiotropium partially relieves exertional dyspnea and reduces the
Kitada S, Hiraga T, Maekura R, Yoshimura K, Tateishi Y, Miki M, Miki K   +6 more
doaj  

Tiotropium

DMW - Deutsche Medizinische Wochenschrift, 2006
europepmc   +3 more sources

Improvement in self-reported exercise participation with the combination of tiotropium and rehabilitative exercise training in COPD patients

International Journal of COPD, 2008
Steven Kesten1, Richard Casaburi2, David Kukafka3, Christopher B Cooper41Boehringer Ingelheim GmbH, Ingelheim, Germany; 2Harbor-UCLA Medical Center, Torrance, CA, USA; 3Northern Colorado Pulmonary Consultants PC, Fort Collins, CO, USA; 4UCLA School of ...
Steven Kesten, Richard Casaburi, David Kukafka, Christopher B Cooper   +3 more
doaj  

Effect of tiotropium/olodaterol on sedentary and active time in patients with COPD: post hoc analysis of the VESUTO® study

International Journal of COPD, 2019
Yoshiaki Minakata,1 Takashi Motegi,2 Jun Ueki,3 Yasuhiro Gon,4 Shuhei Nakamura,5 Tatsuhiko Anzai,6 Kazuto Hirata,7 Masakazu Ichinose81Department of Respiratory Medicine, National Hospital Organization Wakayama Hospital, Wakayama, Japan; 2Department of ...
Minakata Y, Motegi T, Ueki J, Gon Y, Nakamura S, Anzai T, Hirata K, Ichinose M   +7 more
doaj  

UK-specific cost-effectiveness of tiotropium + olodaterol fixed-dose combination versus other LAMA + LABA combinations in patients with COPD

ClinicoEconomics and Outcomes Research, 2016
Abigail Tebboth,1 Andrew Ternouth,1 Nuria Gonzalez-Rojas2 1Boehringer Ingelheim Ltd., Bracknell, UK; 2Boehringer Ingelheim GmBH, Ingelheim, Germany Objective: The aim of this study is to assess the cost-effectiveness of other long-acting muscarinic ...
Tebboth A, Ternouth A, Gonzalez-Rojas N
doaj  

Efficacy of tiotropium–olodaterol fixed-dose combination in COPD

International Journal of COPD, 2016
Eric Derom, Guy G Brusselle, Guy F Joos Department of Respiratory Medicine, Ghent University Hospital, Ghent, BelgiumAbstract: Tiotropium–olodaterol, formulated in the Respimat soft-mist inhaler, is an inhaled fixed-dose combination (FDC) of a long-
Derom E, Brusselle GG, Joos GF
doaj  

Safety analysis of long-acting dual bronchodilator after market approval: a real-world study from FDA Adverse Event Reporting System (FAERS) database. [PDF]

J Thorac Dis
Gao S, Zhuang W, Song Q, Yan D, Chen L, Lai Z, Cheng Y, Yang X, Hu S.   +8 more
europepmc   +1 more source

Identifying patients with mild-to-moderate COPD who require intensified initial treatment to control annualized clinically important deterioration. [PDF]

NPJ Prim Care Respir Med
Wang Z, Zhou Y, Guan WJ, Lin J, Cai G, Zheng J, Wu F, Deng Z, Zhong NS, Ran P.   +9 more
europepmc   +1 more source